Dr Samuel V Rizzo, MD in Jenkins Township, PA - Otolaryngology

Dr Samuel V Rizzo, MD is a Otolaryngology physician based in Jenkins Township, Pennsylvania. Dr Samuel V Rizzo is licensed to practice in Pennsylvania (license number MD038035L) and his current practice location is 795 Township Blvd, Jenkins Township, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (570) 654-3341.

NPI number for Dr Samuel V Rizzo is 1518929231 and his current mailing address is 795 Township Blvd, Jenkins Township, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1518929231.

Contact Information

	Dr Samuel V Rizzo, MD
	795 Township Blvd, Jenkins Township, PA 18640
	(570) 654-3341
	(570) 654-3503

Physician's Profile

Full Name	Dr Samuel V Rizzo
Gender	Male
Speciality	Otolaryngology
Location	795 Township Blvd, Jenkins Township, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1518929231
Provider Enumeration Date: 04/06/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Samuel V Rizzo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518929231	NPI	-	NPPES
0010011920001	Medicaid	PA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	MD038035L (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Samuel V Rizzo is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Samuel V Rizzo, MD 795 Township Blvd, Jenkins Township, PA 18640 Ph: (570) 654-3341	Dr Samuel V Rizzo, MD 795 Township Blvd, Jenkins Township, PA 18640 Ph: (570) 654-3341

News Archive

New research highlights security as top concern for healthcare organisations when managing mobile devices

According to new global research conducted by Vanson Bourne and commissioned by Jamf, the leader in Apple management, security is the number one concern when managing mobile devices for staff, but more than a quarter of healthcare IT decision makers (27%) do not feel their organisation's current mobile device management (MDM) solution is up to scratch.

Sexual health clinics should ask patients about domestic violence and abuse

Training clinicians to proactively ask patients about domestic violence is feasible for sexual health clinics to implement and could increase referrals to specialist services, according to a study by Queen Mary University of London and the University of Bristol involving over 4,300 women.

Intermittent preventive treatment could prevent a third of infant malaria cases, study finds

Research into intermittent preventive treatment of malaria in infants (IPTi) found that one-third of malaria cases in African babies can be prevented by giving them regular doses of malaria drugs even if they have not contracted the disease, according to a Lancet study, published on Thursday, Reuters reports. The study found that IPTi "helped children build better immunity to the disease and reduced the risk of the parasite becoming drug-resistant," but "these benefits decrease if treatment is given continuously as a prophylaxis," Reuters writes.

Study shows evidence that intestinal microorganisms can serve as link between diet and colorectal cancer

A new study provides some of the strongest evidence to date that microorganisms living in the large intestine can serve as a link between diet and certain types of colorectal cancer, the lead authors at Dana-Farber Cancer Institute and Massachusetts General Hospital report.

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, announced that preclinical results for CYT997 were presented today in a poster by Cytopia Limited at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts.

Dr Samuel V Rizzo, MD - Otolaryngology in Jenkins Township, PA